Neomycin exerts its antibacterial effects by binding to the 30S ribosomal subunit of bacteria. This binding interferes with the initiation complex of protein synthesis, causing misreading of mRNA, and ultimately leading to the production of faulty proteins and bacterial cell death. This mechanism is particularly effective against a broad spectrum of Gram-negative bacteria and some Gram-positive bacteria.
